NASDAQ:MGEN - Nasdaq -
Gainers Zomedica Corp. (NYSE: ZOM) shares surged 92.2% to close at $0.93 on Monday after surging 21% on Friday. The company, last week, appointed Robert Cohen as Chief Executive...
Miragen Therapeutics (NASDAQ: MGEN) shares are trading higher on Wednesday after the company announced it is acquiring Viridian Therapeutics. No terms were disclosed. Miragen...
Arena Pharmaceuticals (ARNA) beats bottom-line estimates for third-quarter 2020. Mid-stage atopic dermatitis study on etrasimod fails to meet primary endpoint but phase III study may start soon.
It was thrilling to watch MGEN stock spike, and the bull move might not be over as Miragen's new acquisition puts high-need medicine in focus.
Iovance's (IOVA) third-quarter earnings beat estimates. The company is progressing well with development of its lead pipeline candidate.
Sarepta (SRPT) Q3 revenues increase year over year.
Clovis (CLVS) reports mixed third-quarter 2020 results. Sales of the company's sole marketed drug, Rubraca, decline sequentially. Shares plunge.
Perrigo (PRGO) reports decent third-quarter 2020 results. U.S. consumer self-care segment drives sales. Recovery in other two segments encouraging.
Penny Stocks To Watch If Biotech Is Your Focus Right Now
Miragen Therapeutics news of its acquisition of Viridian Therapeutics has MGEN stock skyrocketing on Wednesday.